-
-
-
-
-
-
-
H.C. Wainwright said 'Ignore the Noise' on Capricor Therapeutics (CAPR) and Buy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)
-
-
-
-
-
-
-
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
-
-
-
-
-
-
-
Capricor Therapeutics Announces Pricing of $5.1 Million Offering Priced At-the-Market
-
-
-
-
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

